Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responses

Journal of Medical Microbiology

Volumn 62, Issue , 2013, Pages 1453-1460

  Solomon, Katie ^a   Martin, Alan J ^b   O'Donoghue, Caoilfhionn ^b   Chen, Xinhua ^c   Fenelon, Lynda ^d   Fanning, Séamus ^a   Kelly, Ciarán P ^c   Kyne, Lorraine ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IN VITRO STUDY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MORTALITY; NONHUMAN; PRIORITY JOURNAL;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CONFIDENCE INTERVALS; DIARRHEA; ENTEROTOXINS; HUMANS; IMMUNITY, HUMORAL; INFLAMMATION; ODDS RATIO; PROSPECTIVE STUDIES; RIBOTYPING; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84881608395     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.058479-0     Document Type: Article

References (23)

1. Bakker, D., Smits, W. K., Kuijper, E. J. & Corver, J. (2012). TcdC does not significantly repress toxin expression in Clostridium difficile 630DErm. PLoS ONE 7, e43247.
2. Bauer, M. P., Kuijper, E. J., van Dissel, J. T. & European Society of Clinical Microbiology and Infectious Diseases (2009). European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 15, 1067-1079.
3. Cartman, S. T., Kelly, M. L., Heeg, D., Heap, J. T. & Minton, N. P. (2012). Precise manipulation of the Clostridium difficile chromosome reveals a lack of association between the tcdC genotype and toxin production. Appl Environ Microbiol 78, 4683-4690.
4. Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40, 373-383.
5. Cloud, J., Noddin, L., Pressman, A., Hu, M. & Kelly, C. (2009). Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol 7, 868-873, e2.
6. Cohen, S. H., Tang, Y. J. & Silva, J., Jr (2000). Analysis of the pathogenicity locus in Clostridium difficile strains. J Infect Dis 181, 659-663.
7. Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., Wilcox, M. H., Society for Healthcare Epidemiology of America & Infectious Diseases Society of America (2010). Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31, 431-455.
8. He, X., Wang, J., Steele, J., Sun, X., Nie, W., Tzipori, S. & Feng, H. (2009). An ultrasensitive rapid immunocytotoxicity assay for detecting Clostridium difficile toxins. J Microbiol Methods 78, 97-100.
9. Horn, S. D., Sharkey, P. D. & Bertram, D. A. (1983). Measuring severity of illness: homogeneous case mix groups. Med Care 21, 14-30.
10. Johnson, S. (2012). Clostridium difficile toxins and severe C. difficile infection. J Infect Dis 205, 353-354.
11. Kamiya, S., Reed, P. J. & Borriello, S. P. (1989). Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction. J Med Microbiol 30, 69-77.
12. Kuehne, S. A., Cartman, S. T., Heap, J. T., Kelly, M. L., Cockayne, A. & Minton, N. P. (2010). The role of toxin A and toxin B in Clostridium difficile infection. Nature 467, 711-713.
13. Kyne, L., Warny, M., Qamar, A. & Kelly, C. P. (2000). Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 342, 390-397.
14. Kyne, L., Warny, M., Qamar, A. & Kelly, C. P. (2001). Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 357, 189-193.
15. McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Jr, Kazakova, S. V., Sambol, S. P., Johnson, S. & Gerding, D. N. (2005). An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353, 2433-2441.
16. Pépin, J., Valiquette, L., Alary, M. E., Villemure, P., Pelletier, A., Forget, K., Pépin, K. & Chouinard, D. (2004). Clostridium difficileassociated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171, 466-472.
17. Rupnik, M., Avesani, V., Janc, M., von Eichel-Streiber, C. & Delmée, M. (1998). A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36, 2240-2247.
18. Steele, J., Chen, K., Sun, X., Zhang, Y., Wang, H., Tzipori, S. & Feng, H. (2012). Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models. J Infect Dis 205, 384-391.
19. Stubbs, S. L., Brazier, J. S., O'Neill, G. L. & Duerden, B. I. (1999). PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37, 461-463.
20. Thelestam, M. & Chaves-Olarte, E. (2000). Cytotoxic effects of the Clostridium difficile toxins. Curr Top Microbiol Immunol 250, 85-96.
21. Thibault, A., Miller, M. A. & Gaese, C. (1991). Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol 12, 345-348.
22. Warny, M., Vaerman, J. P., Avesani, V. & Delmée, M. (1994). Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 62, 384-389.
23. Wilson, V., Cheek, L., Satta, G., Walker-Bone, K., Cubbon, M., Citron, D., Gerding, D. N. & Llewelyn, M. J. (2010). Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 50, e77-e81.